| 000 | 01811 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514061826.0 | ||
| 264 | 0 | _c20030819 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood-2002-12-3665 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilhelm, Martin | |
| 245 | 0 | 0 |
_aGammadelta T cells for immune therapy of patients with lymphoid malignancies. _h[electronic resource] |
| 260 |
_bBlood _cJul 2003 |
||
| 300 |
_a200-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aPamidronate |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aReceptors, Antigen, T-Cell, gamma-delta |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 |
_aT-Lymphocytes _xcytology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKunzmann, Volker | |
| 700 | 1 | _aEckstein, Susanne | |
| 700 | 1 | _aReimer, Peter | |
| 700 | 1 | _aWeissinger, Florian | |
| 700 | 1 | _aRuediger, Thomas | |
| 700 | 1 | _aTony, Hans-Peter | |
| 773 | 0 |
_tBlood _gvol. 102 _gno. 1 _gp. 200-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2002-12-3665 _zAvailable from publisher's website |
| 999 |
_c12419236 _d12419236 |
||